These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21058193)

  • 1. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.
    Clouser MC; Roe DJ; Foote JA; Harris RB; Alberts DS
    Nutr Cancer; 2010; 62(8):1058-66. PubMed ID: 21058193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
    Clouser MC; Roe DJ; Foote JA; Harris RB
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group.
    Tangrea JA; Edwards BK; Taylor PR; Hartman AM; Peck GL; Salasche SJ; Menon PA; Benson PM; Mellette JR; Guill MA
    J Natl Cancer Inst; 1992 Mar; 84(5):328-32. PubMed ID: 1738183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
    Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
    J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
    Jones E; Korzenko A; Kriegel D
    J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
    Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS
    Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
    Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
    J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
    Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
    Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
    Brewster AM; Lee JJ; Clayman GL; Clifford JL; Reyes MJ; Zhou X; Sabichi AL; Strom SS; Collins R; Meyers CA; Lippman SM
    J Clin Oncol; 2007 May; 25(15):1974-8. PubMed ID: 17513803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.
    Dorgan JF; Boakye NA; Fears TR; Schleicher RL; Helsel W; Anderson C; Robinson J; Guin JD; Lessin S; Ratnasinghe LD; Tangrea JA
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1276-82. PubMed ID: 15298946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
    Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
    J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.
    Tangrea J; Edwards B; Hartman A; Taylor P; Peck G; Salasche S; Menon P; Winton G; Mellette R; Guill M
    Control Clin Trials; 1990 Dec; 11(6):433-50. PubMed ID: 1963135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
    Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin.
    Tangrea JA; Kilcoyne RF; Taylor PR; Helsel WE; Adrianza ME; Hartman AM; Edwards BK; Peck GL
    Arch Dermatol; 1992 Jul; 128(7):921-5. PubMed ID: 1626958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotretinoin for the treatment of squamous cell carcinoma arising on an epidermoid cyst.
    Skroza N; Proietti I; Tolino E; Bernardini N; La Viola G; Nicolucci F; Pampena R; Mancini MT; Balduzzi V; Potenza C; Zuber S
    Dermatol Ther; 2014; 27(2):94-6. PubMed ID: 24703265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.